Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.66 USD
Change Today +0.03 / 1.84%
Volume 31.1K
As of 5:20 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ECHO THERAPEUTICS INC (ECTE)

Echo Therapeutics, Inc. to Report Q1, 2014 on May 09, 2014
CapIQ 05/09/2014 4:00 AM ET
Echo Therapeutics, Inc. to Report Fiscal Year 2013 on Mar 27, 2014
CapIQ 05/09/2014 4:00 AM ET
Echo Therapeutics, Inc. to Report Q3, 2013 on Nov 07, 2013
CapIQ 05/09/2014 4:00 AM ET

2013 revenues at Echo Therapeutics, Inc. totaled $27.6K USD, while annual losses equaled $2.86 per share.

Quarterly Earnings & Estimates - ECHO THERAPEUTICS INC (ECTE)

Actuals vs. Estimates for ECHO THERAPEUTICS INC ECTE

Echo Therapeutics, Inc.'s Quarterly Earnings

Echo Therapeutics, Inc. reported 2nd quarter 2014 losses of $0.31 per share on 08/16/2014.

Annual Earnings & Estimates - ECHO THERAPEUTICS INC (ECTE)

Chart not available

Echo Therapeutics, Inc.'s Annual Earnings

Echo Therapeutics, Inc. reported annual 2013 losses of $2.86 per share on 03/29/2014.

Quarterly Revenues - ECHO THERAPEUTICS INC (ECTE)

Actuals vs. Estimates for ECHO THERAPEUTICS INC ECTE

Echo Therapeutics, Inc.'s Quarterly Revenues

Echo Therapeutics, Inc. had 2nd quarter 2014 revenues of $19.1K USD. This missed the $23.0K USD estimate of the one analyst following the company. This was -15.3% below the prior year's 2nd quarter results.

Annual Revenues - ECHO THERAPEUTICS INC (ECTE)

Actuals vs. Estimates for ECHO THERAPEUTICS INC ECTE

Echo Therapeutics, Inc.'s Annual Revenues

Echo Therapeutics, Inc. had revenues for the full year 2013 of $27.6K USD. This was 439.1% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECTE:US $1.66 USD +0.03

ECTE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $48.94 USD 0.00
Bayer AG €128.34 EUR -2.77
Johnson & Johnson $99.98 USD -0.06
Roche Holding AG SFr.275.30 CHF -4.40
View Industry Companies
 

Industry Analysis

ECTE

Industry Average

Valuation ECTE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 492.7x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 455.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ECHO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.